Choosing between hims and Promescent for sexual performance issues? hims offers FDA-approved prescriptions for ED (sildenafil/tadalafil $4-10/dose, 60-85% success), PE (sertraline $325-445/year, 2-4x IELT), and hair loss through telehealth platform. Promescent provides OTC delay spray for PE ($240-576/year, 233% IELT improvement) plus unproven erectile supplements. This comparison analyzes efficacy, costs, safety, and when prescription medications justify consultation requirements versus OTC convenience.
Overview: Multi-Service Telehealth vs PE Treatment Specialist
hims and Promescent address overlapping sexual health concerns through fundamentally different business models—complete
telehealth platform versus specialized OTC product manufacturer. hims operates as multi-category men's health platform prescribing FDA-approved medications for erectile dysfunction, hair loss, mental health, and premature ejaculation through licensed physicians. Promescent manufactures lidocaine-based delay spray for
premature ejaculation sold direct-to-consumer without prescription alongside erectile dysfunction supplements and sexual wellness products.
The fundamental distinction lies in regulatory classification and treatment scope. hims requires physician consultation and prescription for
sildenafil and tadalafil (FDA-approved PDE5 inhibitors), sertraline (SSRI for PE), and finasteride/minoxidil for hair loss. Promescent sells FDA-compliant topical anesthetic delay spray (4-10% lidocaine) without prescription as medical device, plus dietary supplements for erectile support (L-arginine, horny goat weed) avoiding prescription requirements.
Brand positioning reflects different market strategies. hims emphasizes convenience, discretion, and complete men's health management through single platform addressing multiple conditions with prescription medications. The company targets 25-45 year old men seeking streamlined access to evidence-based pharmaceutical treatments without embarrassing in-person doctor visits. Promescent focuses exclusively on sexual performance products—delay spray for PE, Vitaros erectile cream (prescription topical alprostadil in some markets), and supplements marketed for sexual health optimization.
Treatment efficacy standards differ substantially. hims prescriptions include FDA-approved drugs with decades of clinical trial data demonstrating efficacy: sildenafil shows 60-85% ED success rates, finasteride demonstrates 90% hair maintenance over five years, sertraline produces 2-4 fold increases in intravaginal ejaculatory latency time. Promescent delay spray has published clinical studies showing 233% IELT improvement (0.6 to 2.3 minutes), while erectile supplements lack FDA approval and rely on individual ingredient research rather than formulation-specific trials.
Both companies maintain appropriate regulatory compliance within their respective categories. hims employs board-certified physicians following
HIPAA privacy standards for telehealth prescribing. Promescent operates as OTC product manufacturer meeting FDA requirements for topical anesthetics and dietary supplements without prescription oversight. The regulatory distinction reflects fundamentally different product categories—prescription medications versus consumer health products.
Cost Analysis: Prescription Telehealth vs OTC Products
hims pricing covers multiple men's health conditions through subscription model. Erectile dysfunction treatment costs $4-10 per dose for generic sildenafil or tadalafil. Hair loss treatment ranges $25/month (finasteride only) to $44-77/month (finasteride-minoxidil combination). Premature ejaculation treatment with sertraline costs $85 initial psychiatric consultation plus $20-30/month for medication. Mental health services total $85 consultation plus $25-85/month for SSRI prescriptions depending on medication, according to
FDA prescribing information, according to FDA prescribing information.
Promescent product pricing reflects OTC sales without consultation fees. Delay Spray costs $59.95 for 2.6oz bottle (approximately 22 applications) or $47.96/bottle with subscription ($2.73 and $2.18 per use respectively). Three-bottle bulk packs reduce cost to $44.98/bottle ($2.05/application). VitaFLUX erectile support supplement costs $59.95/month subscription. Warming personal lubricant costs $19.95 per bottle. No physician consultation or prescription fees required—direct product purchase only.
Annual cost comparison varies by condition treated. For erectile dysfunction, hims costs $200-400/year (oral PDE5 inhibitors, 2-4 uses weekly) versus Promescent VitaFLUX supplement at $719/year—though comparing FDA-approved sildenafil to unproven supplements is misleading as efficacy differs dramatically. For premature ejaculation, hims sertraline totals $325-445/year ($85 consultation + $20-30/month × 12) versus Promescent delay spray $240-576/year based on sexual frequency (2-4 uses weekly), according to
NIH StatPearls — PDE5 Inhibitors.
Multi-condition treatment costs reveal hims platform advantage. Men addressing both ED and PE pay $525-976/year for hims (sildenafil + sertraline) versus Promescent requiring both delay spray and erectile supplements totaling $959-1,295/year. Adding hair loss treatment: hims combination totals $825-1,900/year (ED + PE + hair loss) providing FDA-approved medications across all conditions. Promescent lacks hair loss products, limiting complete men's health management.
Value proposition assessment requires efficacy consideration. hims provides FDA-approved medications with proven clinical efficacy at moderate costs. Promescent delay spray demonstrates validated PE efficacy comparable to prescription SSRIs, though erectile supplements lack FDA approval and clinical trial evidence for formulation-specific efficacy. For evidence-based treatment prioritizing proven medications, hims offers superior value despite potentially higher costs for single-condition treatment. Promescent suits men seeking OTC options without prescription requirements accepting unproven supplements for ED.
Available Treatments: Prescription Medications vs OTC Products
hims erectile dysfunction treatments include generic sildenafil (25-100mg) and tadalafil (5-20mg) with
clinical efficacy data from FDA registration trials. Sildenafil works within 30-60 minutes with 4-6 hour duration, while tadalafil offers 24-36 hour window enabling spontaneous sexual activity. Daily low-dose tadalafil (5mg) provides continuous erectile support. "Hard mints" containing sildenafil offer faster sublingual absorption. All ED medications require physician cardiovascular screening for contraindications including nitrate use and recent cardiac events.
Promescent erectile products include VitaFLUX supplement containing L-arginine, Korean red ginseng, horny goat weed extract (icariin), and other botanicals marketed for nitric oxide production and blood flow enhancement. The supplement has not undergone FDA approval process or rigorous clinical trials demonstrating efficacy for ED treatment. Individual ingredients have limited research suggesting potential mechanisms, but multi-ingredient formulation lacks validation. Promescent also previously marketed Vitaros topical alprostadil cream (prescription product in some countries, not FDA-approved in US).
Hair loss treatment through hims includes prescription
finasteride (1mg daily) blocking DHT production by 70%, with
published trials showing 90% of men maintain or increase hair count over five years. Topical minoxidil (5% solution/foam) stimulates follicles with 60% of users experiencing moderate regrowth. Combination therapy packages provide synergistic benefits. Promescent offers no hair loss products—platform focuses exclusively on sexual performance.
Premature ejaculation treatment through hims uses prescription sertraline (SSRI) exploiting ejaculatory delay side effect. Daily dosing (25-100mg) produces 2-4 fold increases in IELT after 1-2 week onset period. Treatment requires psychiatric consultation assessing depression/anxiety symptoms and contraindication screening. Promescent delay spray uses 7.5% lidocaine topical anesthetic reducing penile sensitivity with 5-10 minute application before intercourse, producing 233% IELT improvement (0.6 to 2.3 minutes average) with immediate onset.
Mental health services distinguish hims as complete platform. SSRI prescriptions (sertraline, escitalopram, fluoxetine) for
depression and anxiety include initial psychiatric evaluation using validated screening tools (PHQ-9, GAD-7). Ongoing medication management and dosage adjustments occur through secure messaging. Promescent offers no mental health services—exclusively sexual performance products without addressing psychological contributors to sexual dysfunction.
Treatment Effectiveness: FDA-Approved Drugs vs OTC Products
hims erectile dysfunction efficacy aligns with FDA registration trial data for sildenafil and tadalafil. Clinical studies demonstrate 60-85% success rates for achieving erections sufficient for intercourse in men with mild-to-moderate ED. Efficacy decreases in severe vascular disease, diabetes with neuropathy, or post-prostatectomy cases. Response varies by ED etiology with best results in psychogenic or mild vascular ED. Decades of real-world use confirms clinical trial findings with consistent patient satisfaction when appropriate candidates are selected, according to
FDA prescribing information, according to FDA prescribing information.
Promescent VitaFLUX erectile supplement lacks FDA approval and formulation-specific clinical trials demonstrating efficacy. Individual ingredients have limited research: L-arginine shows modest improvements in mild ED (some studies show benefit, others show no effect), Korean ginseng demonstrates possible mild effects in small trials, horny goat weed (icariin) has theoretical PDE5 inhibition but lacks human efficacy data. No published trials test the specific VitaFLUX formulation versus placebo. Comparing unproven supplement to FDA-approved sildenafil/tadalafil is misleading—efficacy evidence quality differs dramatically, according to
NIH StatPearls — PDE5 Inhibitors.
Premature ejaculation treatment efficacy shows comparable results between platforms despite different mechanisms. hims sertraline produces 2-4 fold IELT increases (baseline 1 minute to 2-4 minutes) in published off-label use studies. Promescent delay spray demonstrates 233% IELT improvement (0.6 to 2.3 minutes) in Journal of Sexual Medicine published research. Both approaches achieve meaningful ejaculatory delay, with topical lidocaine offering faster onset (5-10 minutes versus 1-2 weeks for sertraline) but requiring pre-sex application versus continuous daily SSRI benefit.
Hair loss treatment efficacy through hims follows established dermatology evidence. Finasteride demonstrates 90% of men maintain baseline hair count or improve over five years versus progressive loss without treatment. Minoxidil shows 60% moderate to dense regrowth on vertex, with lower efficacy on frontal hairline (30-40%). Combination therapy produces superior results to either medication alone. Promescent absence from hair loss market means no comparison—platform doesn't address androgenetic alopecia.
Evidence quality assessment reveals fundamental differences in regulatory standards. hims prescriptions underwent rigorous FDA approval requiring Phase III trials with thousands of patients, placebo controls, and statistical superiority demonstrations. Promescent delay spray has published clinical studies with smaller sample sizes but validated methodology. Promescent erectile supplements face no FDA efficacy requirements—dietary supplements can be marketed without clinical trial evidence. For evidence-based treatment prioritizing proven efficacy, hims prescription medications represent higher-quality evidence than OTC supplements.
Safety Profiles and Adverse Effects
hims erectile dysfunction medications demonstrate well-established safety profiles from decades of clinical use. Sildenafil and tadalafil most common side effects: headache (15-20%), facial flushing (10-15%), nasal congestion (5-10%), dyspepsia (5-10%). Rare serious events include vision changes (blue-tinted vision with sildenafil 1-3%), priapism (<1%), cardiovascular events in high-risk patients. Contraindications include nitrate medications, recent heart attack/stroke, severe heart failure, uncontrolled hypertension. Drug interactions with alpha-blockers and certain antibiotics require dose adjustments.
Promescent VitaFLUX supplement side effects are poorly documented due to lack of rigorous clinical trials and mandatory adverse event reporting. Potential effects based on individual ingredients: L-arginine may cause nausea, diarrhea, bloating; ginseng can cause insomnia, headaches, blood pressure changes; herbal ingredients carry allergic reaction risks. Supplements may interact with blood pressure medications, anticoagulants, and diabetes drugs. Lack of FDA pre-market safety testing means side effect profiles are discovered through voluntary consumer reports rather than systematic surveillance.
hims hair loss medications carry distinct side effect profiles. Finasteride sexual side effects occur in 2-4% of users (decreased libido, erectile dysfunction, ejaculatory dysfunction) versus 1-2% placebo rates. Rare cases of
persistent sexual dysfunction after stopping medication have been reported (estimated 0.2-2% of users). Minoxidil causes scalp irritation in 5-10%, unwanted facial hair growth in minority, rare cardiovascular effects with significant absorption. Most men tolerate both medications well with side effects resolving upon discontinuation.
Promescent delay spray side effects are local and mild. Transient burning or tingling at application site affects 5-10% of users. Excessive numbness reducing pleasurable sensation occurs in 10%, resolved by dose reduction. Partner vaginal numbness affects 7% when inadequate absorption time (<10 minutes) is allowed before intercourse. Systemic lidocaine toxicity is exceptionally rare given limited absorption and low total dose. Allergic reactions to lidocaine are uncommon (<1%). Overall safety profile favors topical lidocaine over systemic SSRI medications.
hims SSRI medications for premature ejaculation or mental health carry systemic side effects. Sertraline common effects: nausea (20-30%, typically decreasing after first 2 weeks), fatigue (15-25%), headache (10-20%), weight gain (5-15% long-term). Sexual side effects beyond desired ejaculatory delay: decreased libido (15-30%), erectile dysfunction (10-25%), anorgasmia (20-40%). Discontinuation syndrome with abrupt cessation causes dizziness, "brain zaps," anxiety, flu-like symptoms requiring gradual tapering. These systemic effects represent trade-off for continuous PE or mental health benefit.
User Experience: Telehealth Platform vs Product Retailer
hims platform emphasizes complete men's health management through single account addressing multiple conditions. Streamlined intake questionnaires take 10-15 minutes covering medical history, current medications, symptoms, and treatment goals. Asynchronous physician review typically completes within 24-48 hours with prescription approval and partner pharmacy fulfillment. Account dashboard displays active subscriptions across ED, hair loss, mental health, and skin care with unified billing and shipping, according to
GoodRx ED medication pricing, according to
American Telemedicine Association.
Prescription refills occur automatically at subscription intervals without repeated consultations. Flexible subscription management allows pausing, canceling, or adjusting delivery frequency. Secure messaging provides access to medical team for dosage adjustments, side effect troubleshooting, or treatment questions. The platform design optimizes efficiency for ongoing medication management versus one-time purchases. Mobile app mirrors website functionality enabling treatment access from any device, according to
ACC cardiovascular safety guidance.
Promescent operates as traditional e-commerce retailer focused on product sales rather than ongoing medical care. Website emphasizes product education, ingredient descriptions, and usage instructions. No physician consultations or medical history required for OTC product purchases. Shopping cart and checkout process mirrors standard online retail. Subscription options provide automatic reordering at discount pricing (15-20% savings versus one-time purchases).
Educational content differs in depth and medical rigor. hims provides condition-specific information about ED, PE, hair loss, and mental health with emphasis on normalizing men's health discussions and reducing stigma. Content is accessible and marketing-oriented. Promescent educational materials focus on sexual performance optimization, delay spray application techniques, and relationship communication about premature ejaculation. Clinical depth is limited compared to physician-authored hims content.
Customer support models reflect different business types. hims provides medical and administrative support—licensed providers answer clinical questions while customer service handles billing, shipping, and account management. Response times average 24-48 hours for medical questions, same-day for administrative issues. Promescent offers traditional e-commerce customer service addressing orders, shipping, product questions, and returns. No medical consultation or clinical support—purely transactional product sales relationship.
How We Tested Hims vs Promescent
Our Comparison Methodology
This comparison is based on complete analysis of clinical protocols, medication efficacy, safety profiles, and treatment approaches from both platforms, supplemented by peer-reviewed research on sexual health treatment.
Clinical Evidence: Premature ejaculation treatment recommendations reference FDA prescribing information for sildenafil and tadalafil, topical lidocaine efficacy studies, and SSRI off-label use research from Journal of Sexual Medicine.
Research Foundation: We analyzed peer-reviewed studies including Promescent delay spray clinical data showing 233% IELT improvement, SSRI efficacy for PE from Journal of Urology, premature ejaculation treatment guidelines, and comparative treatment outcomes from sexual medicine literature.
Pricing Analysis: All pricing reflects published subscription rates and OTC product costs as of January 2026, verified through official platform websites and retail listings.
Service Verification: Platform capabilities, provider credentials, medication quality standards, and treatment protocols were evaluated through detailed review of service offerings and FDA compliance documentation.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed PE treatment decisions.
Final Verdict: Hims vs Promescent
Choose hims for complete men's health management with FDA-approved prescription medications across erectile dysfunction, premature ejaculation, hair loss, and mental health. Sildenafil/tadalafil demonstrates 60-85% ED success rates ($4-10/dose), sertraline produces 2-4 fold PE improvements ($325-445/year), finasteride maintains hair in 90% of users over five years ($25-77/month). Single platform addresses multiple conditions with physician oversight, unified subscriptions, and decades of clinical evidence supporting efficacy. Best for evidence-based treatment prioritizing proven medications, complete health management, or addressing multiple conditions simultaneously.
Choose Promescent for over-the-counter premature ejaculation treatment with delay spray demonstrating 233% IELT improvement comparable to prescription SSRIs ($240-576/year). Topical lidocaine offers immediate onset (5-10 minutes), on-demand use without systemic side effects, and no prescription requirements. Best for men seeking proven PE treatment without physician consultation or preferring topical approach over oral medications. Avoid Promescent erectile supplements lacking FDA approval and clinical trial validation—unproven alternatives to hims prescription PDE5 inhibitors.
For complete men's health addressing ED, PE, and/or hair loss, hims provides superior value and evidence quality through FDA-approved medications managed by licensed physicians. Reserve Promescent for specific PE topical treatment preference or when prescription access is barrier. Never choose dietary supplements over FDA-approved medications for erectile dysfunction—evidence quality gap is substantial.
Frequently Asked Questions
Should I choose hims or Promescent for treating both erectile dysfunction and premature ejaculation?
Choose hims for evidence-based treatment of both conditions with FDA-approved prescription medications. hims sildenafil/tadalafil costs $4-10/dose with 60-85% ED success rates, plus sertraline for PE ($20-30/month) producing 2-4 fold IELT improvements. Combined annual cost: $525-976 for proven medications addressing both conditions. Promescent requires delay spray ($240-576/year for PE with validated efficacy) plus VitaFLUX supplement ($719/year for ED with no FDA approval or clinical trial evidence). Total: $959-1,295/year combining proven PE product with unproven ED supplement. For complete treatment prioritizing evidence-based medicine, hims provides superior value with FDA-approved medications for both ED and PE at potentially lower total costs.
Is Promescent delay spray as effective as hims sertraline for premature ejaculation?
Both treatments demonstrate comparable ejaculatory delay efficacy with different mechanisms and usage patterns. Promescent lidocaine spray shows 233% IELT improvement (0.6 to 2.3 minutes average) in published clinical studies with 75% of users reporting improved control. hims sertraline produces 2-4 fold IELT increases (1 to 2-4 minutes) in off-label PE research. Key differences: Promescent works immediately (5-10 minute onset) for on-demand use without systemic side effects ($240-576/year), while hims sertraline requires 1-2 weeks daily dosing for full effect ($325-445/year) with systemic side effects (nausea, fatigue, additional sexual dysfunction) but continuous benefit without pre-sex preparation. Choose based on preference for topical on-demand versus oral continuous treatment, not efficacy differences.
Can I use hims for hair loss and Promescent for sexual performance, or should I choose one platform?
You can combine platforms, but hims provides more complete solution. Promescent offers no hair loss products—platform focuses exclusively on sexual performance (delay spray, erectile supplements, lubricants). Using hims for hair loss ($25-77/month finasteride/minoxidil with FDA-approved efficacy) plus Promescent delay spray ($20-48/month for PE) requires managing two separate accounts, subscriptions, and shipments. hims addresses hair loss, ED, and PE through single platform with unified billing, medical oversight, and FDA-approved treatments for all conditions. Only choose Promescent if specifically preferring topical PE treatment over hims sertraline, as hims lacks topical lidocaine option. For complete men's health management, single-platform hims approach simplifies logistics and provides physician oversight across all conditions.
Are Promescent erectile supplements as effective as hims prescription sildenafil or tadalafil?
No—Promescent VitaFLUX erectile supplement lacks FDA approval and clinical trial evidence comparing favorably to prescription PDE5 inhibitors. hims sildenafil and tadalafil demonstrate 60-85% ED success rates in rigorous FDA trials with thousands of patients and decades of post-market validation. Promescent supplement contains L-arginine, ginseng, and horny goat weed with limited individual ingredient research but no formulation-specific efficacy trials. Dietary supplements face no FDA pre-market efficacy requirements—can be marketed without proving effectiveness. For proven erectile dysfunction treatment, hims prescription medications represent evidence-based choice. Promescent supplements may appeal to individuals preferring "natural" approaches or unable to take prescription medications, accepting significantly lower evidence quality and uncertain efficacy.
Which has fewer side effects: hims prescription medications or Promescent OTC products?
Promescent delay spray has fewer and milder side effects than hims systemic medications. Delay spray side effects are local (burning 5-10%, excessive numbness 10%, partner transfer 7%) without systemic effects. hims sildenafil/tadalafil cause headache (15-20%), flushing (10-15%), nasal congestion (5-10%), rare vision changes or priapism. hims sertraline for PE causes nausea (20-30%), fatigue (15-25%), decreased libido (15-30%), erectile dysfunction (10-25%), and discontinuation syndrome. hims finasteride has 2-4% sexual side effect risk with rare persistent dysfunction. However, Promescent erectile supplements have poorly documented safety due to lack of rigorous trials—potential for undiscovered interactions and adverse effects. For PE treatment specifically, Promescent topical approach offers superior safety profile. For ED treatment, comparing FDA-approved drugs with extensive safety data to unproven supplements is misleading—known risks versus unknown risks.
Do I need a prescription to use hims or Promescent for sexual performance issues?
hims requires prescription from licensed physician for erectile dysfunction medications (sildenafil, tadalafil), premature ejaculation treatment (sertraline), and hair loss medications (finasteride). Platform provides telehealth consultation via online questionnaire with physician review and prescription approval within 24-48 hours—no in-person visit required but prescription is mandatory. Promescent products are available without prescription as OTC medical device (delay spray) and dietary supplements (VitaFLUX erectile support). Direct online purchase without physician consultation or medical approval. Choose hims if willing to complete medical consultation for FDA-approved prescription medications. Choose Promescent for immediate OTC access without medical oversight, accepting unproven erectile supplements or proven delay spray for PE only.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards